Atezolizumab, an immune checkpoint inhibitor, caused precedent depressive symptoms related to limbic encephalitis

Corresponding Author

Kunihiro Iwamoto MD, PhD

Department of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan

Correspondence: Kunihiro Iwamoto, MD, PhD Department of Psychiatry, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa, Nagoya, Aichi 466-8550, Japan Tel: +81 52 744 2282; Fax: +81 52 744 2293 Email: iwamoto@med.nagoya-u.ac.jp

Search for more papers by this author

留言 (0)

沒有登入
gif